Discover
STOK
Stoke Therapeutics, Inc.
24.74
2 x 18.06
2 x 31.15
bid
ask
+
0.79
3.30%
2 @ 05:34 PM
24.74 +0.00 (0.00%)
| Ytd | -22.05% | |
| 1y | -17.26% |
23.98
day range
25.20
22.37
52 week range
38.35
| Open | 23.98 | Prev Close | 23.95 | Low | 23.98 | High | 25.20 | Mkt Cap | 1.60B |
| Vol | 918.96K | Avg Vol | 855.13K | EPS | -3.38 | P/E | N/A | Forward P/E | -7.04 |
| Beta | 1.26 | Short Ratio | 13.74 | Inst. Own | 125.34% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-03 | 50-d Avg | 29.51 | 200-d Avg | 31.49 | 1yr Est | 46.46 |
| Income Statement | |||
| Total Revenue | 9.32M | ||
| Revenues (USD) | 9.32M | ||
| Gross Profit | 9.32M | ||
| Operating Expenses | 74.75M | ||
| Research and Development Expense | 49.50M | ||
| Selling, General and Administrative Expense | 25.25M | ||
| Operating Income | -65.43M | ||
| Interest Expense | -3.50M | ||
| Net Income | -61.62M | ||
| Net Income Common Stock | -61.62M | ||
| Net Income Common Stock (USD) | -61.62M | ||
| Consolidated Income | -61.62M | ||
| Earnings per Basic Share | -0.93 | ||
| Earnings per Basic Share (USD) | -0.93 | ||
| Earnings per Diluted Share | -0.93 | ||
| Earning Before Interest & Taxes (EBIT) | -65.12M | ||
| Earning Before Interest & Taxes (USD) | -65.12M | ||
| Weighted Average Shares | 66.02M | ||
| Weighted Average Shares Diluted | 66.02M | ||
| Balance Sheet | |||
| Cash and Equivalents | 110.00M | ||
| Cash and Equivalents (USD) | 110.00M | ||
| Investments | 247.54M | ||
| Investments Current | 182.81M | ||
| Investments Non-Current | 64.73M | ||
| Trade and Non-Trade Receivables | 7.18M | ||
| Current Assets | 322.54M | ||
| Property, Plant & Equipment Net | 6.70M | ||
| Total Assets | 393.97M | ||
| Current Liabilities | 41.93M | ||
| Total Liabilities | 48.42M | ||
| Accumulated Retained Earnings (Deficit) | -609.34M | ||
| Accumulated Other Comprehensive Income | -542.00K | ||
| Shareholders Equity | 345.55M | ||
| Shareholders Equity (USD) | 345.55M | ||
| Assets Non-Current | 71.43M | ||
| Deferred Revenue | 14.18M | ||
| Liabilities Non-Current | 6.49M | ||
| Trade and Non-Trade Payables | 4.79M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.14M | ||
| Net Cash Flow from Financing | 1.91M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -45.65M | ||
| Capital Expenditure | -1.98M | ||
| Issuance (Purchase) of Equity Shares | 1.91M | ||
| Net Cash Flow from Investing | 9.02M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 10.99M | ||
| Net Cash Flow from Operations | -56.58M | ||
| Share Based Compensation | 10.80M | ||